Safety and utilization of blood components as therapeutic delivery systems.

Safety and utilization of blood components as therapeutic delivery systems. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Safety and utilization of blood components as therapeutic delivery systems. Abstract Text:

In recent years, natural blood components have been extensively studied as the advanced therapeutic delivery systems. The blood components which can potentially be used as the therapeutic delivery systems include different types of cells, such as erythrocytes and lymphocytes, macromolecular complexes such as lipoproteins and antibody or albumin conjugates and other molecules. This review article covers the progress in this topic, specifically, including the safety issues and the utilization of these component. It can be seen through the literature that the blood components as the therapeutic delivery systems have a number of advantages over traditional pharmaceutical products. The efficacy and practice of the applications, however, require significant amount of development work in the near future.

Safety and utilization of blood components as therapeutic delivery systems. Publishing Authors By Initials

For similar pharmaceutical preparations research abstracts see: pharmaceutical preparations research

PUBMED ID PMID:

MEDLINE DATE:

Safety and utilization of blood components as therapeutic delivery systems. Journal Published:

PUBLICATION TYPE: Review

Journal: Current pharmaceutical biotechnology

VOLUME: 4

Page Numbers: 275-82

Journal Abbreviation: Curr Pharm Biotechnol

ISSN: 1389-2010

DAY: 12

MONTH: Oct

YEAR: 2003

Safety and utilization of blood components as therapeutic delivery systems. Information

Number of References: 69

LANGUAGE: eng

NlmUniqueID: 100960530

Safety and utilization of blood components as therapeutic delivery systems. Keywords Mesh Terms:

KEYWORDS: Pharmaceutical Preparations

MESH TERMS: administration & dosage

Chemical & Substance for Abstract: Safety and utilization of blood components as therapeutic delivery systems. Information

Substance Name: Pharmaceutical Preparations

Registry Number: 0

Grant and Affiliation Information for Safety and utilization of blood components as therapeutic delivery systems.

AFFILIATION: Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602, USA.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Pharm Biotechnol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Safety and utilization of blood components as therapeutic delivery systems Related Publications

• Educational diagnosis of self-management behaviors of parents with asthmatic children by triangulation based on PRECEDE-PROCEED model in Taiwan.
• Effect of transforming growth factor-beta(2) on extracellular matrix synthesis in bovine trabecular meshwork cells.
• Influence of abnormal cervical pap smear undertaken during pregnancy to the outcome of the pregnancy.
• WT1 downregulation during K562 cell differentiation and apoptosis induced by bufalin.
• [Analysis of three-dimensional microstructure of poly(lactide-co-glycolide) scaffolds made by mild heating under high pressure]
• [Changes in plasma levels of adrenomedullin and cyclic adenosine monophosphate and their interrelation in patients with chronic heart failure]
• [Clinical significance of serum troponin I in patients with acute left heart failure]
• [Cloning and expression of the gene of recombinant augmenter of liver regeneration in yeast]
• [Collection, processing and cryopreservation of placental cord blood hematopoietic stem cells]
• [Construction of pcDNA3.1AM and expression of adrenomedullin in mammalian cells]
• [Cytogenetic analysis on 1058 cases of acute nonlymphocytic leukemia]
• [Determination of domoic acid in water and aquatic animals by high performance liquid chromatography]
• [Diagnosing achondroplasia by single cell nested-PCR]
• [Different effects of acetylcholine on the action potential and force contraction in guinea pig atrial and ventricular myocardium]
• [Effect of tumor necrosis factor-alpha on differentiation of mesencephalic neural stem cells and proliferation of oligodendrocytes in the rat]
• [Heterogeneity of action potential and ion currents in the left ventricular myocytes of the rabbit]
• [Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia]
• [Human peripheral blood monocyte derived dendritic cell culture and mature regulation]
• [Inhibition of proliferation and induction of apoptosis by simvastatin in K562 leukemic cell line]
• [MK-801 suppresses dynorphin A (1-17)-induced facilitation of nociceptive responses to formalin in rats]
• [Molecular cytogenetic detection of partial chromosome 13q trisomy and its relation with the clinical features of tortilcollis]
• [Non-Hodgkin's lymphoma in the lacrimal gland: report of one case]
• [Reactive oxygen species and mitochondrial KATP-sensitive channels mediated cardioprotection induced by TNF-alpha during hypoxia and reoxygenation]
• [Relationship between soluble Fas ligand levels and complications after allogeneic bone marrow transplantation]
• [Relationship of I/D polymorphism of angiotensin converting enzyme gene with hypertension in Xinjiang Kazakh isolated group]
• [Sequencing of the glyceraldehyde-3-phosphate dehydrogenase gene from Plasmodium falciparum strain FCC1/HN]
• [Study on defibrinogenasing enhancing the thrombolytic effect of urokinase on acute myocardial infarction]
• [Study on preparation of beta-cyclodextrin inclusion compound of volatile oil from Aucklandia lappa]
• [The determination of F-, Cl-, NO3- and SO(4)2- in the total suspended particles in air by ion chromatography]
• [Treatment of primary trauma in the brainstem: analysis of 126 cases]